Literature DB >> 9178812

MHC-dependent cytolysis of autologous tumor cells by lymphocytes infiltrating urothelial carcinomas.

F Housseau1, D Zeliszewski, M Roy, V Paradis, S Richon, A Ricour, J Bougaran, D Prapotnich, G Vallancien, G Benoit, L Desportes, P Bedossa, T Hercend, J M Bidart, D Bellet.   

Abstract

Tumor-infiltrating lymphocytes (TIL) were grown from 23 urothelial carcinomas. Phenotyping analysis showed that the TIL cultures were mainly CD3+. Although CD4+ and CD8+ T-cell sub-sets were grown in culture, CD4+ T-cell sub-sets predominated over CD8+ T cells. Immunohistochemical studies performed on 5 tumor specimens confirmed this observation, and indicated that CD4+ T cells surrounded the tumor islets, whereas CD8+ T lymphocytes were localized among the tumor cells. Five short-term carcinoma cell lines established from these urothelial tumors were used as target cells in cytolysis assays in order to investigate the functional anti-tumor activity of autologous TIL. TIL from 4/5 tumors were lytic and 3 TIL lines displayed MHC-class-I-dependent cytotoxicity directed against autologous tumor cells. CD4+ T-cell-depletion experiments performed on TIL line 07 confirmed that CD8+ MHC-class-I-dependent CTL were the predominant effectors. Finally, experiments performed on 6 allogeneic urothelial-cancer cell lines matched for HLA-class-I molecules showed that TIL07 exhibited selective lytic activity toward tumor 07. These data indicate that CD8+ MHC-class-I-dependent CTL present in urothelial carcinomas are functional and may participate in the anti-tumor immune response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178812     DOI: 10.1002/(sici)1097-0215(19970516)71:4<585::aid-ijc13>3.0.co;2-b

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Relative efficacy of uptake and presentation of Mycobacterium bovis BCG antigens by type I mouse lung epithelial cells and peritoneal macrophages.

Authors:  Mandavi Kumari; Rajiv K Saxena
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

Review 2.  Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.

Authors:  Chrysoula I Liakou; Sowmita Narayanan; Derek Ng Tang; Christopher J Logothetis; Padmanee Sharma
Journal:  Cancer Immun       Date:  2007-06-26

Review 3.  The immunoregulatory mechanisms of carcinoma for its survival and development.

Authors:  Caigan Du; Yuzhuo Wang
Journal:  J Exp Clin Cancer Res       Date:  2011-01-21

4.  Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns.

Authors:  V Dangles; V Lazar; P Validire; S Richon; M Wertheimer; V Laville; J-L Janneau; M Barrois; C Bovin; T Poynard; G Vallancien; D Bellet
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

5.  An essential role for decorin in bladder cancer invasiveness.

Authors:  Mohamed El Behi; Sophie Krumeich; Catalina Lodillinsky; Aurélie Kamoun; Lorenzo Tibaldi; Gaël Sugano; Aurélien De Reynies; Elodie Chapeaublanc; Agnès Laplanche; Thierry Lebret; Yves Allory; François Radvanyi; Olivier Lantz; Ana María Eiján; Isabelle Bernard-Pierrot; Clotilde Théry
Journal:  EMBO Mol Med       Date:  2013-10-20       Impact factor: 12.137

6.  Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer.

Authors:  Michael Poch; MacLean Hall; Autumn Joerger; Krithika Kodumudi; Matthew Beatty; Pasquale P Innamarato; Brittany L Bunch; Mayer N Fishman; Jingsong Zhang; Wade J Sexton; Julio M Pow-Sang; Scott M Gilbert; Philippe E Spiess; Jasreman Dhillon; Linda Kelley; John Mullinax; Amod A Sarnaik; Shari Pilon-Thomas
Journal:  Oncoimmunology       Date:  2018-07-23       Impact factor: 8.110

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.